DE69622863D1 - Verwendung von hydroxyethylstärke zur verhinderung postoperativer adhäsion und als träger für innenhohlräume - Google Patents

Verwendung von hydroxyethylstärke zur verhinderung postoperativer adhäsion und als träger für innenhohlräume

Info

Publication number
DE69622863D1
DE69622863D1 DE69622863T DE69622863T DE69622863D1 DE 69622863 D1 DE69622863 D1 DE 69622863D1 DE 69622863 T DE69622863 T DE 69622863T DE 69622863 T DE69622863 T DE 69622863T DE 69622863 D1 DE69622863 D1 DE 69622863D1
Authority
DE
Germany
Prior art keywords
hes
hydroxyethyl
carrier
strength
postoperative adhesion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69622863T
Other languages
English (en)
Other versions
DE69622863T2 (de
Inventor
Stodder Dizerega
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southern California USC
Original Assignee
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23915271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69622863(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University of Southern California USC filed Critical University of Southern California USC
Publication of DE69622863D1 publication Critical patent/DE69622863D1/de
Application granted granted Critical
Publication of DE69622863T2 publication Critical patent/DE69622863T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
DE69622863T 1995-06-07 1996-05-31 Verwendung von hydroxyethylstärke zur verhinderung postoperativer adhäsion und als träger für innenhohlräume Expired - Fee Related DE69622863T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/482,235 US5807833A (en) 1995-06-07 1995-06-07 Hydroxyethyl starch and use thereof as an absorbable mechanical barrier and intracavity carrier device
PCT/US1996/008098 WO1996040168A2 (en) 1995-06-07 1996-05-31 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device

Publications (2)

Publication Number Publication Date
DE69622863D1 true DE69622863D1 (de) 2002-09-12
DE69622863T2 DE69622863T2 (de) 2002-12-12

Family

ID=23915271

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69622863T Expired - Fee Related DE69622863T2 (de) 1995-06-07 1996-05-31 Verwendung von hydroxyethylstärke zur verhinderung postoperativer adhäsion und als träger für innenhohlräume

Country Status (9)

Country Link
US (1) US5807833A (de)
EP (1) EP0831856B1 (de)
JP (2) JP4184431B2 (de)
AT (1) ATE221782T1 (de)
AU (1) AU722836B2 (de)
CA (1) CA2223573C (de)
DE (1) DE69622863T2 (de)
ES (1) ES2177787T3 (de)
WO (1) WO1996040168A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807833A (en) * 1995-06-07 1998-09-15 University Of Southern California Hydroxyethyl starch and use thereof as an absorbable mechanical barrier and intracavity carrier device
BR9911769B8 (pt) * 1998-05-13 2021-06-22 Innovata Ltd composição para impedir ou reduzir a incidência de aderências pós-operatória em ou associadas com uma cavidade do corpo, kit de prevenção de adesão pós-operatória biocompatível, bioabsorvível e não tóxico e produtos ompreendendo a dita composição
GB9810127D0 (en) 1998-05-13 1998-07-08 Ml Lab Plc Prevention of surgical adhesions
CN1479592A (zh) * 2000-12-05 2004-03-03 ���ռ����ɷ����޹�˾ 使红细胞沉降的方法
US7332179B2 (en) 2003-12-12 2008-02-19 Kimberly-Clark Worldwide, Inc. Tissue products comprising a cleansing composition
EP1809303B1 (de) * 2004-09-23 2019-03-06 ARC Medical Devices, Inc. Pharmazeutische zusammensetzungen und verfahren zur hemmung von fibröser adhäsion oder entzündungserkrankung mit niedermolekularen sulfat-fucanen
US7642395B2 (en) 2004-12-28 2010-01-05 Kimberly-Clark Worldwide, Inc. Composition and wipe for reducing viscosity of viscoelastic bodily fluids
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
US9119901B2 (en) * 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
CN101485897B (zh) * 2008-01-14 2015-05-20 纪欣 生物相容性止血、防粘连、促愈合、外科封闭的变性淀粉材料
US20090062233A1 (en) 2007-08-09 2009-03-05 Xin Ji Modified starch material of biocompatible hemostasis
EP2832360A1 (de) 2013-07-30 2015-02-04 Fresenius Kabi Deutschland GmbH Polysaccharid zur Verwendung bei der Prävention der Bildung von Metastasen und/oder Rezidiven

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE456346B (sv) * 1984-07-23 1988-09-26 Pharmacia Ab Gel for att forhindra adhesion mellan kroppsvevnader och sett for dess framstellning
EP0234897A3 (de) * 1986-02-24 1987-11-19 Ethicon, Inc. Inhibition der postoperativen Adhäsionsbildung durch kontinuierliche topische Verabreichung von Glucocorticoiden
US4913903A (en) * 1987-02-04 1990-04-03 Alza Corporation Post-surgical applications for bioerodible polymers
US5080893A (en) * 1988-05-31 1992-01-14 University Of Florida Method for preventing surgical adhesions using a dilute solution of polymer
SE8900586L (sv) * 1989-02-21 1990-08-22 Pharmacia Ab Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader
US5219895A (en) * 1991-01-29 1993-06-15 Autogenesis Technologies, Inc. Collagen-based adhesives and sealants and methods of preparation and use thereof
JP3174400B2 (ja) * 1992-05-28 2001-06-11 味の素ファルマ株式会社 腹腔洗浄液
DE4242926C2 (de) * 1992-12-18 1994-12-15 Fresenius Ag Dialyselösung für die Peritonealdialyse
US5807833A (en) * 1995-06-07 1998-09-15 University Of Southern California Hydroxyethyl starch and use thereof as an absorbable mechanical barrier and intracavity carrier device
US5639468A (en) * 1995-06-07 1997-06-17 University Of Southern California Method for reducing or preventing post-surgical adhesion formation using manoalide and analogs thereof

Also Published As

Publication number Publication date
CA2223573C (en) 2011-09-20
JP4184431B2 (ja) 2008-11-19
AU5956996A (en) 1996-12-30
AU722836B2 (en) 2000-08-10
WO1996040168A3 (en) 1997-01-23
JP2008264495A (ja) 2008-11-06
ES2177787T3 (es) 2002-12-16
EP0831856B1 (de) 2002-08-07
DE69622863T2 (de) 2002-12-12
WO1996040168A2 (en) 1996-12-19
EP0831856A2 (de) 1998-04-01
CA2223573A1 (en) 1996-12-19
ATE221782T1 (de) 2002-08-15
US5807833A (en) 1998-09-15
JPH11506741A (ja) 1999-06-15

Similar Documents

Publication Publication Date Title
CA2220505C (en) N,o-carboxymethylchitosan for prevention of surgical adhesions
DE69622863T2 (de) Verwendung von hydroxyethylstärke zur verhinderung postoperativer adhäsion und als träger für innenhohlräume
CA2174072A1 (en) Hydrogel-forming, self-solvating absorbable polyester block copolymers, and methods for use thereof
BRPI0512604A (pt) terapia de drogas em combinação para reduzir a formação de tecido de cicatrização
EP0952171A3 (de) Hydrogelbildende, selbst-solvatisierende, absorbierbare Polyestercopolymere sowie Verfahren zu deren Verwendung
CA2344222A1 (fr) Mousse proteique adhesive a usage chirurgical et/ou therapeutique
HK1090750A1 (en) Methods of preparing radium-223, and pharmaceutically acceptable agents and reagent set
GR3034921T3 (en) Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer.
CA2235919A1 (en) Non-polymeric sustained release delivery system
ATE246522T1 (de) Implantierbare medizinische vorrichtung mit antiinfektiösen und kontrazeptiven eigenschaften
FI83729B (fi) Kirurgisk implantat.
AU5647996A (en) Artificial skin containing as support biocompatible materials based on hyaluronic acid derivatives
CA2257976A1 (en) Compositions and methods for coating medical devices
GB2357969A (en) Improvements in or relating to the treatment of lesions
ATE325580T1 (de) Resorbierbare, verformbare knochenplatte
EP1712228A3 (de) HyaluronsäurederivateI zur Vorbeugung sowie Behandlung von Hautnarben
HK1028210A1 (en) Use of hyaluronic acid derivatives in the preparation of biomaterials
ATE260124T1 (de) Stoffzusammensetzung zur gewebebildung
CA2340320A1 (en) Use of an angiogenic factor for the treatment of microascular angiopathies
DK0772446T3 (da) Anti-adhæsionsmiddel
FR2793651B1 (fr) Solution aqueuse de conservation de tissus et d'organes
EP1162956B8 (de) Zusammensetzungen und verfahren zur verbesserung der integrität von angegriffenen körperpassagewegen und höhlen
DE69426530D1 (de) Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz
CO5280202A1 (es) Metodos de tratamiento y metodos de rastreo de farmacos
ES2126117T3 (es) Agente desinfectante quimico a base de componentes fenolicos activos y glutaraldehido.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee